CN108333272A - The method of LC-MSMS method separation determination PAS and its related impurities - Google Patents

The method of LC-MSMS method separation determination PAS and its related impurities Download PDF

Info

Publication number
CN108333272A
CN108333272A CN201810173832.1A CN201810173832A CN108333272A CN 108333272 A CN108333272 A CN 108333272A CN 201810173832 A CN201810173832 A CN 201810173832A CN 108333272 A CN108333272 A CN 108333272A
Authority
CN
China
Prior art keywords
solution
acid
mobile phase
pas
acetonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810173832.1A
Other languages
Chinese (zh)
Inventor
颜波
谭辉
陈丽娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Huapont Pharm Co Ltd
Original Assignee
Chongqing Huapont Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Huapont Pharm Co Ltd filed Critical Chongqing Huapont Pharm Co Ltd
Priority to CN201810173832.1A priority Critical patent/CN108333272A/en
Publication of CN108333272A publication Critical patent/CN108333272A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Abstract

The invention belongs to medicinal chemistry arts, and in particular to a kind of method of LC MSMS method separation determination PAS and its related impurities.The chromatographic column used in the method is to use aqueous acetic acid and acetonitrile solution to carry out gradient elution for mobile phase using octyl silane group silica gel as filler, be detected into tandem mass spectrum detector;The related impurities include m-nitrobenzene sulfonic acid and metanilic acid.This method can detect the content of PAS intermediate nitro benzene sulfonic acid and metanilic acid simultaneously, the screening of mobile phase type, the optimization of eluent gradient, the selection of chromatographic column, eliminate interference of the PAS to metanilic acid and nitre benzene sulfonic acid, so that the rate of recovery that limit is added is more than 95%, and detection limit has reached 0.4ng/ml.

Description

The method of LC-MSMS method separation determination PAS and its related impurities
Technical field
The invention belongs to medicinal chemistry arts, and in particular to a kind of LC-MSMS methods separation determination PAS and its The method of related impurities.
Background technology
Tuberculosis is the chronic infectious disease caused by mycobacterium tuberculosis infection, and the Chinese scientific name of tubercle bacillus is tuberculosis branch bar Bacterium (M.tuberculosis).Containing lipid in Mycobacterium tuberculosis cell wall, lipid can prevent thalline loss of moist, therefore to dry Dry resistance is especially strong.It is adhered on dust and keeps infectiousness 8-10 days, can survive in dry phlegm 6-8 months.Tuberculosis point The variations such as form, bacterium colony, virulence, immunogenicity and drug resistance can occur for branch bacillus.Currently, treatment lungy mostly uses Li Fu Flat, isoniazid, ethambutol, streptomysin are First Line drug.Rifampin can reduce the generation of drug resistance with isoniazid. To severe infections, can be heightened the effect of a treatment with pyrazinamide and rifampin and isoniazid with reducing the generation of drug resistance.
The entitled 4- amino-2-hydroxybenzoic acids of PAS chemistry, fusing point are 135-145 DEG C, are treating tuberculosis branches The drug of bacillus, PAS can delay generation of the mycobacterium tuberculosis to isoniazid and streptomycin resistance, make May be to inhibit folic acid synthesis (but confrontation folic acid compound is without synergistic effect) and/or inhibit the life of cell wall mycobacteria with mechanism The synthesis of long element makes the iron of mycobacterium tuberculosis take in and reduces, to reach bacteriostasis.PAS is only to branch bar Bacterium is effective, and tubercle bacillus can generate rapidly drug resistance when being used alone, therefore this product must be shared with other anti-tubercular drugs.
The preparation method of PAS bulk pharmaceutical chemicals report at present there are mainly two types of method:One is be with phenylacetic acid Material synthesis obtains PAS;Another kind is to obtain PAS through hydroxylation by meta-aminophenol.
In document Journal of the American Chemical Society [1948,70 (4), 1665-1666] It is raw material to report with phenylacetic acid, PAS is obtained by the reaction through 6 steps, equation is as follows:
Patent DE50835 is reported prepares PAS by raw material of meta-aminophenol, and reactional equation is as follows:
It is noted that PAS is a very unstable compound, it is all quicker to light, heat, oxygen Sense, at 40 DEG C or more, PAS aqueous solution or its hydrochloride meeting decarboxylize are degraded into impurity m-aminophenol, are in Brown solution.
According to technological line analysis, it is possible to create the process contaminants of metanilic acid and nitre benzene sulfonic acid, the impurity contain There is genotoxicity caution structure, according to the requirement of ICH, needs strictly to control such impurity, limit 0.8ppm.Using Conventional HPLC-UV method sensitivity cannot be satisfied testing requirements, therefore, next there is an urgent need to provide a kind of method of high sensitivity Detect genotoxicity caution structure impurity in aminosalicylic acid.
There is no the methods using LC-MSMS detection metanilic acid and nitre benzene sulfonic acid at present, therefore provide a kind of Simply, separating degree is good, method of high sensitivity can more accurately ensure PAS and its preparation it is quality controllable, and most The safe and effective of product is determined eventually.
Invention content
In view of this, the purpose of the present invention is to provide a kind of LC-MSMS methods separation determination PAS and its phases The method for closing impurity.The method can detect containing for PAS intermediate nitro benzene sulfonic acid and metanilic acid simultaneously Amount, detection limit have reached 0.4ng/ml.
To achieve the above object, the technical scheme is that:
The method of LC-MSMS (Liquid Chromatography-Tandem Mass Spectrometry) method separation determination PAS and its related impurities, institute It is using octyl silane group silica gel as filler, using aqueous acetic acid (mobile phase A) and second to state the chromatographic column used in method Nitrile aqueous solution (Mobile phase B) is that mobile phase carries out gradient elution, is detected into tandem mass spectrum detector;The related impurities Including m-nitrobenzene sulfonic acid and metanilic acid.
Further, the percent by volume in the aqueous acetic acid shared by acetic acid is 0.1%.
Further, the percent by volume in the acetonitrile solution shared by acetonitrile is 90%.
Further, the condition setting of the gradient elution is as follows:
Flow rate of mobile phase is 0.3-0.5ml/min.
As a preferred embodiment, the condition setting of the gradient elution is as follows:
Flow rate of mobile phase is 0.4ml/min.
Pass through the optimization of eluent gradient, the screening of mobile phase type, the selection of chromatographic column, exclusion in the method for the present invention Interference of the PAS to metanilic acid and nitre benzene sulfonic acid so that the rate of recovery that limit is added is more than 95%, And detection limit has reached the extremely low concentration of 0.4ng/ml.
Further, the method for the LC-MSMS methods separation determination PAS and its related impurities, specifically include with Lower step:
1) inner mark solution is prepared:It takes p-methyl benzenesulfonic acid solubilizer to dissolve and dilutes, obtain inner mark solution;
2) test solution is prepared:Test sample is taken, 0.1mlN is added, adds again after N- dimethylacetylamides and inner mark solution Solvent is dissolved and is diluted, and obtains test solution;
3) reference substance solution is prepared:M-nitrobenzene sulfonic acid and metanilic acid are taken respectively, and 0.1mlN, N- dimethyl is added Solubilizer is dissolved and is diluted after acetamide and inner mark solution, obtains reference substance solution;
4) reference substance solution and test solution sample introduction in liquid chromatograph are taken respectively, are examined using tandem mass spectrum detector It surveys, records chromatogram, the content of m-nitrobenzene sulfonic acid and metanilic acid is calculated by internal standard method.
As a preferred embodiment, in the above method, sampling volume is 20 μ l.
Further, the solvent is the acetonitrile solution that acetonitrile percent by volume is 20%.
Further, in step 1) inner mark solution a concentration of 1ng/ml;A concentration of 1230 μ of test solution in step 2) g/ml-1270μg/ml。
As a preferred embodiment, in step 2) test solution a concentration of 1250 μ g/ml.
Mobile phase original ratio contains 80% water phase, and the organic Phase Proportion of test solution is excessively high, has apparent solvent effect It answers, interference measurement, so in test solution process for preparation, a small amount of n,N-dimethylacetamide is added and increases to amino The phenomenon that salicylic dissolubility has dropped organic Phase Proportion that test solution prepares solvent, greatly reduces solvent interference.
In the above method, percent by volume of the n,N-dimethylacetamide in test solution or reference substance solution is 1%.
Further, in step 4) chromatographic column of liquid chromatograph specification be 250 × 4.6mm, 5.0 μm;The chromatographic column Post case temperature is 25-35 DEG C.
As a preferred embodiment, the chromatographic column post case temperature is 30 DEG C.
Further, in step 4) tandem mass spectrum detector condition:Electric spray ion source (ESI), using anion MRM moulds Formula detects;Ion source temperature is 550 DEG C, and spray voltage is -3000v, and atomization gas (Gas1) is 15psi;Gas curtain gas (Curtain Gas) it is 12psi.
The second object of the present invention is to provide the reagent set of a kind of separation determination PAS and its related impurities Object is closed, the reagent composition is made of mobile phase A, Mobile phase B and n,N-dimethylacetamide;The mobile phase A is acetic acid Aqueous solution, the percentage in aqueous acetic acid shared by acetic acid are 0.1%;The Mobile phase B is acetonitrile solution, acetonitrile solution Percentage shared by middle acetonitrile is 90%;The related impurities include m-nitrobenzene sulfonic acid and metanilic acid.
Percent by volume of the DMAC N,N' dimethyl acetamide in test solution or reference substance solution is in separation determination 1%.
The beneficial effects of the present invention are:
1) method of LC-MSMS methods separation determination PAS and its related impurities provided by the invention, this method Can detect simultaneously the content of PAS intermediate nitro benzene sulfonic acid and metanilic acid and it is easy to operate, separating degree is good, Specificity is strong, high sensitivity, can accurately ensure the quality controllable of PAS and its preparation, and finally determine product Safely and effectively.
2) it is excluded by the screening of mobile phase type, the optimization of eluent gradient, the selection of chromatographic column in the method for the present invention Interference of the PAS to metanilic acid and nitre benzene sulfonic acid so that the rate of recovery that limit is added is more than 95%, And detection limit has reached the extremely low concentration of 0.4ng/ml.
3) in detection process, the organic Phase Proportion of test solution is excessively high, has apparent solvent effect, interference measurement, institute The dissolving that a small amount of n,N-dimethylacetamide increases PAS in test solution process for preparation, is added Property, the phenomenon that having dropped organic Phase Proportion that test solution prepares solvent, greatly reduce solvent interference.
Description of the drawings
Fig. 1 is the second order ms figure of m-nitrobenzene sulfonic acid.
Fig. 2 is the second order ms figure of metanilic acid.
Fig. 3 is the second order ms figure of p-methyl benzenesulfonic acid.
Fig. 4 is LOD-1 (0.5ng/ml).
Fig. 5 is LOD-2.
Fig. 6 is LOD-3.
Fig. 7 is blank solvent chromatogram.
Fig. 8 is internal standard chromatogram.
Fig. 9 is reference substance chromatogram (1ng/ml).
Figure 10 is test sample chromatogram.
Figure 11 is that test solution adds standard solution chromatogram (1ng/ml).
Specific implementation mode
Hereinafter reference will be made to the drawings, and the preferred embodiment of the present invention is described in detail.Tool is not specified in preferred embodiment The experimental method of concrete conditions in the establishment of a specific crime, usually according to normal condition, illustrated embodiment are to preferably be said to present disclosure It is bright, but be not that present disclosure is only limitted to illustrated embodiment.So those skilled in the art are according to foregoing invention Content carries out nonessential modifications and adaptations to embodiment, still falls within protection scope of the present invention.
Determining instrument:Mass spectrum:API3000, liquid phase:LC-20A
Liquid phase chromatogram condition
Chromatographic column:Agilent XDB-C8 250 × 4.6mm, 5 μm;
Mobile phase:0.1% aqueous acetic acid (mobile phase A), 90% acetonitrile solution (Mobile phase B);
Flow velocity:0.4ml/min.
The condition and parameter of tandem mass spectrum detector:Electric spray ion source (ESI), using anion MRM mode detections;From Source temperature is 550 DEG C, and spray voltage is -3000v, and atomization gas (Gas1) is 15psi;Gas curtain gas (Curtain Gas) is 12psi;Residence time:200msce Resolution Q1:Unit, Resolution Q3:Unit, compound ions are to being shown in figure 1~Fig. 3.
Embodiment
The method of LC-MSMS method separation determination PAS and its related impurities,
1, concrete operation method:
Test sample 12.5mg is taken, it is accurately weighed, it sets in 10ml measuring bottles, 0.1mlN is added, N- dimethylacetylamides are accurate Measurement inner mark solution 1.0ml (take p-methyl benzenesulfonic acid appropriate, it is accurately weighed, it is dissolved with 20% acetonitrile solution and quantifies dilution system At the solution containing 10ng in every 1ml) it sets in 10ml measuring bottles, it is dissolved with 20% acetonitrile solution and is quantitatively diluted to scale, shaken up, made For test solution;Take m-nitrobenzene sulfonic acid and metanilic acid reference substance appropriate, it is accurately weighed, it is molten with 20% acetonitrile solution It solves and quantifies dilution and the solution containing 10ng in every 1ml is made, precision measures solution 1.0ml, sets in 10ml measuring bottles, then accurate amount Inner mark solution 1.0ml is taken, is set in the same measuring bottle, 0.1mlN is added, N- dimethylacetylamides are diluted to 20% acetonitrile solution Scale shakes up, as a contrast product solution.According to high performance liquid chromatography (Chinese Pharmacopoeia 0,512 first method of version general rule in 2015) It measures, is stationary phase (5 μm of 250mm*4.6mm) with eight alkyl linked silica gel;Using 0.1% glacial acetic acid aqueous solution as mobile phase A, using 90% acetonitrile solution as Mobile phase B, gradient elution, column temperature is 30 DEG C, flow velocity 0.4ml/min.
Condition of gradient elution:
Electric spray ion source (ESI), using anion MRM mode detections, ion source temperature is 550 DEG C, spray voltage is- 3000v, atomization gas (Gas1) are 15;Gas curtain gas (Curtain Gas) is 12, and ion information see the table below.Take reference substance molten respectively Liquid and 20 μ l sample introductions of test solution, record chromatogram.Test solution intermediate nitro benzene sulfonic acid and metanilic acid difference It is not greater than reference substance solution intermediate nitro benzene sulfonic acid and metanilic acid and internal standard peak area with the ratio of internal standard peak area Ratio (0.00008%).
2, testing result:
Blank solvent does not interfere m-nitrobenzene sulfonic acid, metanilic acid and interior target to measure in the detection;Internal standard is not done Disturb the measurement of m-nitrobenzene sulfonic acid and metanilic acid;Reference substance solution sample introduction repeatability is good, sees Fig. 7~Fig. 9.
3, the detection of detection limit m-nitrobenzene sulfonic acid and metanilic acid is limited to 0.5ng/ml, is equivalent to aminosalicyclic The impurity of the 0.4ppm of acid can be detected, and signal-to-noise ratio is more than 3, sees Fig. 4~Fig. 6.
4, Standard entertion experiment PAS does not interfere metanilic acid and nitro this sulphur measurement
Precision weighs sample 12.5mg, sets in 10ml measuring bottles, and 0.1mlN, N- dimethylacetylamides, then precision respectively is added The internal standard stock solution (10ng/ml) and reference substance stock solution (10ng/ml) 1.0ml under specificity item are measured, is set in measuring bottle, then is added Solvent is quantitatively diluted to scale, shakes up, and as testing liquid is added, takes 20 μ l sample introductions, records chromatogram, see Figure 11.
Precision weighs sample 12.5mg, sets in 10ml measuring bottles, and 0.1mlN, N- dimethylacetylamides is added, and precision measures special Internal standard stock solution 1.0ml under attribute item, sets in measuring bottle, then solubilizer is quantitatively diluted to scale, shakes up, molten as test sample Liquid takes 20 μ l sample introductions, records chromatogram, sees Figure 10.
Precision measures internal standard stock solution and reference substance stock solution 1.0ml under specificity item, sets in 10ml measuring bottles, is added 0.1mlN, N- dimethylacetylamide, solubilizer dissolve simultaneously be quantitatively diluted to scale, shake up, as a contrast product solution, take 20 μ l into Sample records chromatogram, sees Fig. 9.
Finally illustrate, the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although with reference to compared with Good embodiment describes the invention in detail, it will be understood by those of ordinary skill in the art that, it can be to the skill of the present invention Art scheme is modified or replaced equivalently, and without departing from the objective and range of technical solution of the present invention, should all be covered at this In the right of invention.

Claims (10)

  1. The method of 1.LC-MSMS method separation determination PAS and its related impurities, which is characterized in that adopted in the method Chromatographic column is using octyl silane group silica gel as filler, using aqueous acetic acid (mobile phase A) and acetonitrile solution (stream Dynamic phase B) it is that mobile phase carries out gradient elution, it is detected into tandem mass spectrum detector;The related impurities include between nitro Benzene sulfonic acid and metanilic acid.
  2. 2. according to the method described in claim 1, it is characterized in that, percent by volume in the aqueous acetic acid shared by acetic acid It is 0.1%.
  3. 3. according to the method described in claim 1, it is characterized in that, percent by volume in the acetonitrile solution shared by acetonitrile It is 90%.
  4. 4. according to the method described in claim 1, it is characterized in that, the condition setting of the gradient elution is as follows:
    Flow rate of mobile phase is 0.3-0.5ml/min.
  5. 5. according to claim 1-4 any one of them methods, which is characterized in that specifically include following steps:
    1) inner mark solution is prepared:It takes p-methyl benzenesulfonic acid solubilizer to dissolve and dilutes, obtain inner mark solution;
    2) test solution is prepared:Test sample is taken, solubilizer dissolving again is added after n,N-dimethylacetamide and inner mark solution And dilute, obtain test solution;
    3) reference substance solution is prepared:Take m-nitrobenzene sulfonic acid and metanilic acid respectively, be added n,N-dimethylacetamide and Solubilizer is dissolved and is diluted after inner mark solution, obtains reference substance solution;
    4) reference substance solution and test solution sample introduction in liquid chromatograph are taken respectively, are detected using tandem mass spectrum detector, Chromatogram is recorded, the content of m-nitrobenzene sulfonic acid and metanilic acid is calculated by internal standard method.
  6. 6. according to the method described in claim 5, it is characterized in that, the solvent is the acetonitrile that acetonitrile percent by volume is 20% Aqueous solution.
  7. 7. according to the method described in claim 5, it is characterized in that, in step 1) inner mark solution a concentration of 1ng/ml;Step 2) a concentration of 1230 μ g/ml-1270 μ g/ml of test solution in.
  8. 8. according to the method described in claim 5, it is characterized in that, the specification of the chromatographic column of liquid chromatograph is in step 4) 250 × 4.6mm, 5.0 μm;The chromatographic column post case temperature is 25-35 DEG C.
  9. 9. according to the method described in claim 5, it is characterized in that, in step 4) tandem mass spectrum detector condition:Electron spray Ion source (ESI), using anion MRM mode detections;Ion source temperature is 550 DEG C, and spray voltage is -3000v, atomization gas (Gas1) it is 15psi;Gas curtain gas (Curtain Gas) is 12psi.
  10. 10. the reagent composition of separation determination PAS and its related impurities, which is characterized in that the reagent composition It is made of mobile phase A, Mobile phase B and DMAC N,N' dimethyl acetamide;The mobile phase A is aqueous acetic acid, in aqueous acetic acid Percentage shared by acetic acid is 0.1%;The Mobile phase B is acetonitrile solution, the percentage in acetonitrile solution shared by acetonitrile It is 90%;The related impurities include m-nitrobenzene sulfonic acid and metanilic acid.
CN201810173832.1A 2018-03-02 2018-03-02 The method of LC-MSMS method separation determination PAS and its related impurities Pending CN108333272A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810173832.1A CN108333272A (en) 2018-03-02 2018-03-02 The method of LC-MSMS method separation determination PAS and its related impurities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810173832.1A CN108333272A (en) 2018-03-02 2018-03-02 The method of LC-MSMS method separation determination PAS and its related impurities

Publications (1)

Publication Number Publication Date
CN108333272A true CN108333272A (en) 2018-07-27

Family

ID=62930178

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810173832.1A Pending CN108333272A (en) 2018-03-02 2018-03-02 The method of LC-MSMS method separation determination PAS and its related impurities

Country Status (1)

Country Link
CN (1) CN108333272A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109799292A (en) * 2018-12-28 2019-05-24 重庆健能医药开发有限公司 A kind of related substance-measuring method of Mesalazine enema fluid
CN110133118A (en) * 2018-12-28 2019-08-16 重庆健能医药开发有限公司 A kind of related substance-measuring method of Mesalazine enteric-coated sustained-release tablet
CN110441434A (en) * 2019-08-29 2019-11-12 重庆华邦胜凯制药有限公司 The method of related impurities in GC-MS separation determination PAS
CN112924613A (en) * 2021-01-31 2021-06-08 中南大学湘雅医院 LC-MS/MS method for quantitatively analyzing plasma concentration of antituberculotic

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2020286A (en) * 1978-05-09 1979-11-14 Unitika Ltd Aromatic sulphonic acid adducts useful as flame retardantsfor polyamides
CN1404487A (en) * 2000-01-20 2003-03-19 卡比斯特制药公司 High purity lipopeptides, lipopeptide micelles, process for preparing same
JP2014181185A (en) * 2013-03-18 2014-09-29 Toray Fine Chemicals Co Ltd Method for manufacturing diamine compound
CN104402749A (en) * 2014-11-28 2015-03-11 重庆华邦制药有限公司 Novel crystal form of p-aminosalicylic acid as well as preparation method and applications thereof
CN106248825A (en) * 2016-07-21 2016-12-21 山东省分析测试中心 The detection method of starting material A in hydrochloride landiolol material medicine
CN106699611A (en) * 2016-12-30 2017-05-24 沈阳化工研究院有限公司 Production method for preparing sodium m-aminobenzene sulfonate by means of continuous hydrogenation reduction
CN107337658A (en) * 2016-05-03 2017-11-10 沈阳药科大学 A kind of synthetic method of the chloro- 2,3- Dihydrobenzofuranes -7- carboxylic acids of butanedioic acid prucalopride intermediate 4- amino -5-

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2020286A (en) * 1978-05-09 1979-11-14 Unitika Ltd Aromatic sulphonic acid adducts useful as flame retardantsfor polyamides
CN1404487A (en) * 2000-01-20 2003-03-19 卡比斯特制药公司 High purity lipopeptides, lipopeptide micelles, process for preparing same
JP2014181185A (en) * 2013-03-18 2014-09-29 Toray Fine Chemicals Co Ltd Method for manufacturing diamine compound
CN104402749A (en) * 2014-11-28 2015-03-11 重庆华邦制药有限公司 Novel crystal form of p-aminosalicylic acid as well as preparation method and applications thereof
CN107337658A (en) * 2016-05-03 2017-11-10 沈阳药科大学 A kind of synthetic method of the chloro- 2,3- Dihydrobenzofuranes -7- carboxylic acids of butanedioic acid prucalopride intermediate 4- amino -5-
CN106248825A (en) * 2016-07-21 2016-12-21 山东省分析测试中心 The detection method of starting material A in hydrochloride landiolol material medicine
CN106699611A (en) * 2016-12-30 2017-05-24 沈阳化工研究院有限公司 Production method for preparing sodium m-aminobenzene sulfonate by means of continuous hydrogenation reduction

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
THOMAS STORM 等: "Use of volatile amines as ion-pairing agents for the high-performance liquid chromatographic-tandem mass spectrometric determination of aromatic sulfonates in industrial wastewater", 《JOURNAL OF CHROMATOGRAPHY A》 *
南京药学院 等: "《药剂学》", 31 March 1978, 人民卫生出版社 *
安登魁 等: "《药物分析 第3版》", 30 June 1992, 人民卫生出版社 *
李春盈 等: "HPLC法测定对氨基水杨酸钠中有关物质的含量", 《广东药学院学报》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109799292A (en) * 2018-12-28 2019-05-24 重庆健能医药开发有限公司 A kind of related substance-measuring method of Mesalazine enema fluid
CN110133118A (en) * 2018-12-28 2019-08-16 重庆健能医药开发有限公司 A kind of related substance-measuring method of Mesalazine enteric-coated sustained-release tablet
CN109799292B (en) * 2018-12-28 2022-02-22 重庆健能医药开发有限公司 Mesalazine enema related substance determination method
CN110441434A (en) * 2019-08-29 2019-11-12 重庆华邦胜凯制药有限公司 The method of related impurities in GC-MS separation determination PAS
CN112924613A (en) * 2021-01-31 2021-06-08 中南大学湘雅医院 LC-MS/MS method for quantitatively analyzing plasma concentration of antituberculotic

Similar Documents

Publication Publication Date Title
CN108333272A (en) The method of LC-MSMS method separation determination PAS and its related impurities
Xu et al. Analysis of colistin A and B in fishery products by ultra performance liquid chromatography with positive electrospray ionization tandem mass spectrometry
Cangemi et al. Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots
Panchal et al. Development and validation of GC/MS method for determination of pramipexole in rat plasma
Li et al. Comparative pharmacokinetics of prim‐O‐glucosylcimifugin and cimifugin by liquid chromatography–mass spectrometry after oral administration of Radix Saposhnikoviae extract, cimifugin monomer solution and prim‐O‐glucosylcimifugin monomer solution to rats
Fan et al. An ultra-performance liquid chromatography–tandem mass spectrometry method to quantify vancomycin in human serum by minimizing the degradation product and matrix interference
Fan et al. Simultaneous separation and determination of vancomycin and its crystalline degradation products in human serum by ultra high performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring
Ahirrao et al. Time-dependent selected reaction monitoring-based GC-MS/MS method for estimation of genotoxic impurities in new antibacterial agent: alalevonadifloxacin mesylate
Zhang et al. Simultaneous determination of harmine, harmaline and their metabolites harmol and harmalol in beagle dog plasma by UPLC–ESI-MS/MS and its application to a pharmacokinetic study
Cai et al. Determination of four pyridine alkaloids from Tripterygium wilfordii Hook. f. in human plasma by high-performance liquid chromatography coupled with mass spectrometry
Song et al. Development of a fast LC‐MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics
Zheng et al. Quantitative and transformation product analysis of major active physalins from Physalis alkekengi var. franchetii (Chinese lantern) using ultraperformance liquid chromatography with electrospray ionisation tandem mass spectrometry and time‐of‐flight mass spectrometry
Sakurai et al. Measurement of linezolid and its metabolites PNU-142300 and PNU-142586 in human plasma using ultra-performance liquid chromatography method
Yang et al. Determination of palonosetron in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Guo et al. A liquid chromatography–tandem mass spectrometry assay for the determination of nemonoxacin (TG‐873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single‐dose pharmacokinetic study in healthy Chinese volunteers
Wang et al. Determination of ethanamizuril, a novel triazine coccidiostat, in rat plasma by ultra‐performance liquid chromatography system‐tandem mass spectrometry and its application in a toxicological study
Saka et al. Determination of amobarbital and phenobarbital in serum by gas chromatography–mass spectrometry with addition of formic acid to the solvent
Qi et al. A UPLC–MS/MS method for simultaneous determination of nine antiepileptic drugs in human plasma and its application in TDM
CN104991027B (en) The method for reducing fixedness buffer salt content in LC MS testers
Farajzadeh et al. A simple and rapid dispersive liquid–liquid microextraction method followed by GC‐FID for determination of N‐methylpyrrolidine in cefepime
Han et al. Development of an LC‐MS/MS‐based assay to determine artemitin in rat plasma and its application in a pharmacokinetic study
Zhao et al. Determination of nimodipine in human plasma by HPLC-ESI-MS and its application to a bioequivalence study
Ren et al. Determination of lomerizine in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study
Zhang et al. Determination of cycloserine in microdialysis samples using liquid chromatography–tandem mass spectrometry with benzoyl chloride derivatization
Pedroso et al. A validated RP–LC method for simultaneous determination of losartan potassium and amlodipine besilate in pharmaceutical preparations

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180727